Si et al. proved that MSC infusion could partially reconstruct islet function and effectively ameliorate hyperglycemia in T2D rats, additionally acting to improve insulin sensitivity by upregulating glucose transporter type 4 expression and elevating phosphorylated insulin receptor substrate 1 and Akt levels in target tissues [131]. The gene discussed is INS; the disease is Hyperglycemia.